Alcohol and other drug treatment are generally only provided for individuals, often away from their families. Treatment aims to improve well-being and reduce the harms of substance use and families and communities can play a significant...
For Immediate Release: May 23, 2023
Today, the U.S. Food and Drug Administration approved Brixadi (buprenorphine) extended-release injection for subcutaneous use (under the skin) to treat moderate to severe opioid use disorder (OUD)...
Substance use disorders (SUDs) are highly prevalent and impact individuals' health, well-being, and social functioning. Long-lasting changes in brain networks involved in reward, executive function, stress reactivity, mood, and...
Presented by Richard Rawson, PhD, Emeritus Professor in the Department of Psychiatry and Biobehavioral Science, UCLA School of Medicine and a Research Professor at the University of Vermont, this presentation provided an overview of the...
In the magazine CIJ Informa, the participation of CIJ, host chapter institution of ISSUP Mexico, in the 71st Regular Session of CICAD is reviewed.
The Anti-Stigma Network has been launched!
The Anti-Stigma Network has been created by a group of organisations coming together with a shared mission.
Collectively they aim to improve understanding of the stigma and...
Background
Opioid dependence is associated with substantial health and social burdens, and opioid agonist treatment (OAT) is highly effective in improving multiple outcomes for people who receive this treatment. Methadone and...
The crisis of opioid use puts a strain on resources in the United States and worldwide. There are 3 US Food and Drug Administration–approved medications for treatment of opioid use disorder: methadone, buprenorphine...
Question What treatments for cocaine use disorder are associated with objective reductions in cocaine use among adults?
Findings In this meta-analysis of 157 clinical trials comprising 402 treatment groups and 15 842...
Cocaine is an addictive stimulant drug that originates from the leaves of the coca plant, which is indigenous to South America. The drug's effects include heightened alertness, attention, and energy, as well as feelings of euphoria and...
The markets for hexahydrocannabinol (HHC) and related semi-synthetic cannabinoids (SSC) are rapidly evolving areas with relatively limited information currently available.
The European situation presented in Section 1 can...
Objective: To better understand current developments in the treatment of stimulant use.
Background: Stimulant drugs are second only to cannabis as the most widely used class of illicit drug globally, accounting for 68 million past...
Substance misuse among young people is one of the most public concerns in global health. This study set out to explore treatment barriers among young people in Zimbabwe.
Data was collected through interviews with 30 participants
The...
It has been widely reported that youth alcohol consumption has decreased over recent years. What is the evidence to support this view? What are the implications for alcohol related health harm, promotion of safe drinking and health policy?
...
This report presents the most recent and in-depth data on overdose and drug-induced deaths in Australia, covering the period 2002 to 2021. It is the most recent output in a series of annual publications on trends in drug overdose deaths...
The Alcohol Use and Mental Health Project ECHO is a no-cost virtual program for health care professionals who are looking for up-to-date and research-based information on working with people who use alcohol.
The program, which is only...
Tom Santo Jr presented at the NDARC Webinar Series on Thursday, 16 February 2023.
How do childhood trauma and mental disorders affect health, treatment and social outcomes among people with opioid dependence?
Research has found that...
The consequences of addiction to substances like drugs and alcohol, or engaging in certain behaviours like gambling, gaming, or sex, can be severe. Addiction is often a response to underlying trauma and social stressors, and continued use...
